360° Risk Intelligence
Use industry-wide data at scale to identify, assess, and predict risks early — so you can act before they turn into disruptions.
Turn signal overload into clarity. Here’s how QYOBO works.
From scattered risk indicators to real prevention: See how QYOBO transforms complex pharma market data into clear, actionable intelligence for proactive risk management.
Monitor all risks in your supplier network in a single solution – purpose-built for Pharma. Track non-compliance events, recalls, inspections, financial health, geopolitical risks and detect exposure before it becomes a problem.
Identify weak links before they become problems with QYOBO’s compliance score and our industry-first warning letter prediction model. Switch to risk-based auditing by focusing on the suppliers with the highest probability of non-compliance — and, through our integration with Rephine®, you’re just one click away from the latest audit data.
Stay informed with near-real-time alerts ranging from inspections or recalls worldwide to deteriorating financial scores of your suppliers. QYOBO alerts you first, and goes further by instantly highlighting the impact in your own or competitor supply chains.
Quantify your exposure to specific manufacturing countries, assess the impact of tariffs or simply benchmark your degree of single-sourcing for a product against your peer group.
Identify suppliers at risk of financial default before they break your supply chain through our integration of S&P Global, Inc.™ RiskGauge™ data – the industry standard in financial risk assessment.
Benefits
While Others Drown in Data, You’re Already Making the Right Moves.
Monitor your entire supply risk in one place — fully tailored to your products, sites, and supplier network. Purpose-built for Pharma and fully integrated with S&P Global™, Rephine® audits, and ESG platforms. No more fragmented tools. No more blind spots.
QYOBO scans 300+ global sources in near real-time, alerting you to inspections, recalls, or rising financial risks — and instantly quantifies the impact on your own or your competitors’ supply chain.
While others react to headlines, QYOBO clients took action months ago — with FDA warning letters predicted up to 6 months in advance, suppliers flagged for overdue inspections, and financial stress detected before it breaks the supply chain.
More capabilities
One Platform. From Insight to Action.
See how QYOBO transforms pharma decision-making with AI-driven insights.
Questions?
Answers to your questions on how 360° Risk Intelligence drives better pharma decisions.
QYOBO consolidates every major supply risk in one place — compliance issues, recalls, inspections, financial defaults, geopolitical exposure, and ESG factors. We also track regulatory data (e.g. lost filings, Form 483s, import alerts) and technical disruptions such as fires, explosions, or shutdowns — ensuring no blind spots in your supply chain.
The platform automatically maps risks to your products, sites, and external supplier network. Instead of generic alerts, you get intelligence that shows exactly how a disruption affects you, your competitors, or your clients.
Yes. Our AI-powered models have a demonstrated history of predicting FDA warning letters 5–6 months in advance, flag suppliers with overdue inspections, and highlight financial stress before defaults occur. You act long before the market reacts.
Yes. QYOBO connects seamlessly with Rephine® audits, S&P Global™ RiskGauge™, and leading ESG providers — giving you a single, unified view of risk. This way you avoid duplication, make the most of your existing data, and gain additional insights in one place.
You receive near real-time alerts from 300+ databases, often weeks or months before traditional channels. For each alert, you instantly see whether it impacts your own supply chain — or whether it creates an opportunity because it affects a competitor instead. It’s not just an alert — it’s actionable competitive intelligence.
